Skip to content

Efficacy of Cinnamon on Menstrual Cyclicity

Efficacy of Cinnamon on Menstrual Cyclicity and Metabolic Dysfunction in Women with Polycystic Ovarian Syndrome

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201706162825N2
Enrollment
41
Registered
2017-07-17
Start date
2015-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovarian Syndrome. Sclerocystic ovary syndrome or Stein-Leventhal syndrome

Interventions

Intervention 1: In intervention group, 1.5 grams of cinnamon daily as two 250 mg capsules TDS for 6 months will be given to the patients. Intervention 2: In control group, placebo (Containing starch)
Treatment - Drugs
In intervention group, 1.5 grams of cinnamon daily as two 250 mg capsules TDS for 6 months will be given to the patients.
In control group, placebo (Containing starch) daily as two 250 mg capsules TDS for 6 months will be given to the patients.

Sponsors

Vice Chancellor for Research of Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: *Inclusion criteria: 18-38 year old women with at least two criteria of Rotterdam criteria for PCO; Low ovulation/ lack of ovulation (oligomenorrhoea/amenorrhea); Clinical or biochemical evidence of increased androgen; Sonography findings for PCO; BMI = 20-50 kg/m2. **Exclusion criteria: Pregnant or lactating women; Under treating infertility; Diagnosed diabetics under treatment; Receiving insulin-stimulating drugs at 3 months prior to participating in the study; Treatment with estrogen or progesterone 3 months prior to participating in the study; Inhaled corticosteroid users; Patients with seizure; Cardiovascular or cerebrovascular diseases; Hypersensitivity to Cinnamon; Women who did not have the appropriate medical or psychological conditions for participation in the study; Women participated in medical research or other surgery on within 28 days.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Menstrual Cyclicity. Timepoint: Monthly. Method of measurement: History; Questionnaire.

Secondary

MeasureTime frame
Metabolic Syndrome. Timepoint: After 6 months. Method of measurement: Physical exam; ELISA kit; Transvaginal sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh Peyvandi

Mazandaran University of Medical Sciences

speivandi@mazums.ac.ir+98 11 3310 5629

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026